ClinicalTrials.Veeva

Menu

HD-tDCS: Effects on the Somatosensory System

A

Aalborg University

Status

Completed

Conditions

Somatosensory Function
Brain Modulation
Neuroplasticity
Acute Pain

Treatments

Device: Dorsolateral Prefrontal Cortex Stimulation
Device: Multimodal Stimulation (DLPFC+M1)
Device: Sham stimulation
Device: Primary Motor Cortex Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04165876
N-20180085.v1

Details and patient eligibility

About

The purpose of this study is to investigate the efficacy of high definition tDCS on different cortical targets in modulating the nociceptive system in the healthy subjects.

Full description

The investigators aim to investigate the efficacy of different HD-tDCS electrode configurations on modulating the somatosensory/nociceptive system.

This is done to investigate the hypothesis, that different stimulation protocols can be used to modulate the somatosensory and nociceptive system, as shown in the previous studies, but that it is necessary to uncover the most efficient way to do so.

The study uses a double-blinded, sham-controlled, longitudinal design, where quantitative sensory testing will be used to assess the somatosensory function of the participants before and after a receiving a specific configuration of HD-tDCS on three consecutive days.

Enrollment

81 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy men and women.
  • Able to speak, read and understand English or Danish.

Exclusion criteria

  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Current use of opioids, antipsychotics, benzodiazepines
  • Previous or current neurological, musculoskeletal, rheumatic, malignant, inflammatory or mental illnesses
  • Current or prior chronic pain conditions
  • Lack of ability to cooperate

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

81 participants in 4 patient groups

Primary motor cortex
Active Comparator group
Treatment:
Device: Primary Motor Cortex Stimulation
Dorsolateral prefrontal cortex
Active Comparator group
Treatment:
Device: Dorsolateral Prefrontal Cortex Stimulation
Multi-modal stimulation (DLPFC+M1)
Active Comparator group
Treatment:
Device: Multimodal Stimulation (DLPFC+M1)
Sham-stimulation
Sham Comparator group
Treatment:
Device: Sham stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems